Article
A pan-cancer analysis of Dyskeratosis congenita 1 (DKC1) as a prognostic biomarker
11 Dec 2023
Abstract excerpt
BACKGROUND: Dyskeratosis congenita 1 (DKC1), a critical component of telomerase complex, is highly expressed in a variety of human cancers. However, the association of DKC1 with cancer occurrence and development stages is not clear, making a pan-cancer analysis crucial. METHODS: We conducted a study using various bioinformatic databases such as TIMER, GEPIA, UALCAN, and KM plotter Analysis to examine the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
